J&J Pauses COVID-19 Vaccine Trials Due To Unexplained Illness In Participant

Stat News reported the pause earlier in the day citing a document sent to outside researchers running the 60,000-patient clinical trial, which stated that a “pausing rule” had been met, the online system used to enroll patients in the study had been closed and the data and safety monitoring board would be convened.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor